Research Todd Berner’s Research Todd Berner Oral Pharmacotherapy for Overactive Bladder in Older Patients: Mirabegron as a Potential Alternative to Antimuscarinics Todd Berner Clinical Burden and Nonpharmacologic Management of Nursing Facility Residents with Overactive Bladder and/or Urinary Incontinence Todd Berner Economic and Clinical Impact of Switching from Antimuscarinics to Mirabegron for the Treatment of Overactive Bladder Todd Berner PUK13. Health Care Costs Among Patients Who Continue Therapy Or Switch Antimuscarinic Agents For Overactive Bladder Todd Berner A Comparison of Daily Average Consumption Of Oxycodone Controlled Release (OxyContin CR) And Oxymorphone Extended Release (Opana ER) In Patients With Low Back Pain Todd Berner PSY40 Extended Release Oxymorphone is Associated with Lower Subjective Monetary Value Than Controlled Release Oxycodone in Nondependent Recreational Opioid Users Todd Berner Diagnosis of Hurler's Syndrome With Chest Roentgenogram Todd Berner Challenges in the Pharmacological Management of Nursing Home Residents with Overactive Bladder or Urinary Incontinence Todd Berner Alpha Blocker Monotherapy Versus Combination Therapy with Antimuscarinics in Men with Persistent LUTS Refractory to Alphaadrenergic Treatment: Patterns of Persistence Todd Berner Healthcare Resource Use and Costs of Privately Insured Patients Who Switch, Discontinue, or Persist on Antimuscarinic Therapy for Overactive Bladder Todd Berner Direct and Indirect Costs of Patients Treated with Extended-Release Oxymorphone HCl or Controlled-Release Oxycodone HCl Todd Berner PSY4 Daily Average Consumption Analysis of Low Back Pain and Osteoarthritis Patients Using Oxymorphone Extended Release and Oxycodone Hydrochloride Controlled Release Tablets in a Commerically Insured Population Todd Berner Scheduled Short-Term Prevention With Frovatriptan for Migraine Occurring Exclusively in Association With Menstruation Todd Berner Blunt Trauma to the Chest
